Compare Stocks: IMA vs. TIL vs. ELTX vs. ALGS
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
IMATILELTXALGS
Market Snapshot
Current market context for the selected companies.
IMA
$5.43
Market Cap
$63.13M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
TIL
$7.88
Market Cap
$51.54M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
ELTX
$2.98
Market Cap
$79.11M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
ALGS
$7.46
Market Cap
$46.65M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
Performance
Absolute returns and relative performance versus SPY.
| Metric | IMA | TIL | ELTX | ALGS |
|---|---|---|---|---|
| 1 Month | -5.7% | +8.1% | +1.2% | +75.5% |
| 1 Month vs SPY | -9.1% | +4.8% | -2.1% | +72.2% |
| 3 Months | -8.4% | -3.2% | -72.3% | +33.2% |
| 3 Months vs SPY | -10.4% | -5.2% | -74.3% | +31.2% |
| 6 Months | -19.2% | -7.8% | -72.8% | +7.5% |
| 6 Months vs SPY | -29.6% | -18.3% | -83.3% | -2.9% |
| 1 Year | -61.6% | -69.4% | -72.9% | -26.9% |
| 1 Year vs SPY | -80.8% | -88.5% | -92.1% | -46.1% |
| 2 Years | -73.8% | -34.3% | -32.0% | -45.7% |
| 2 Years vs SPY | -110.4% | -70.9% | -68.6% | -82.3% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.